AI Terminal
Target Healthcare REIT PLC
Report Publication Announcement • Mar 10, 2022
5028_rns_2022-03-10_c510064b-20fb-47eb-891f-f1794127a280.html
Report Publication Announcement
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 2707E
Target Healthcare REIT PLC
10 March 2022
10 March 2022
Target Healthcare REIT plc and its subsidiaries
("Target Healthcare" or "the Group")
Notice of Half Year Results
Target Healthcare (LSE: THRL), the UK listed specialist investor in modern, purpose-built care homes, will announce its half year results for the six months ended 31 December 2021 on Wednesday 16 March 2022.
A live webcast for investors and analysts will be held at 10:00 a.m. on the day of the results. To register for the webcast or for more details, please contact FTI Consulting at [email protected].
Enquiries:
| Target Fund Managers: Kenneth MacKenzie Gordon Bland |
Tel: +44 (0)1786 845 912 |
| FTI Consulting: Dido Laurimore Claire Turvey Richard Gotla |
Tel: +44 (0)20 3727 1000 [email protected] |
Notes:
UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.
The Group's portfolio at 31 December 2021 comprised 98 assets let to 31 tenants with a total value of £870.5 million.
The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.
LEI: 213800RXPY9WULUSBC04
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NORBKLLBLXLXBBB